ASX - By Stock. A reversal at $0. 1. Created with Sketch. ASX - By Stock. Still early in the day, but it's starting to happen right about when I thought,. Market . . 10:38. KZA Price at posting: 8. 0. Canadian Dollar. 0¢ Change 0. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. . . Top 20 has increased their holdings. Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has been awarded a Rare Paediatric Disease Designation (RPDD) by the US Food and Drug Administration (FDA) for the use of paxalisib in the treatment of atypical rhabdoid/teratoid tumours (AT/RT), a rare and highly aggressive childhood brain cancer. 84% 5. ASX - By Stock. as far as our drug GDC 0084 and a number of imminent conferences. 465. Join the HotCopper ASX share market forum today for free. ASX - By Stock. "Well, Well. 495 and $0. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. 2. Join the HotCopper ASX share market forum today for free. Created with Sketch. , page-3. 25M. Feb 28 (Reuters) - Kazia Therapeutics Ltd (KZA) : HY LOSS AFTER INCOME TAX BENEFIT ATTRIBUTABLE A$13. 5MILLION AND LAUNCHES SHARE PURCHASE PLAN FUNDING WILL BE USED TO. ASX - Day Trading. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. , page-6. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. KZA. . Last updated 15. 465. The web page shows its share price, news, discussions, timeline and corporate information on HotCopper Forum. KAZIA THERAPEUTICS LIMITED - Announcements. An ambiguous announcement like that is way below what should be. 5¢. ASX - General. The material was easy to understand and the speakers were extremely knowledgeable and willing to give in-depth answers to out questions. KZA is an Australia-based oncology-focused drug development company that develops treatments for cancer. MarketMEI Pharma (MEIP) rocketing in the nasdaq. So miles behind, but may. 495 and $0. Click for more information. ASX - Day TradingAbsract- AACR - The dual P13KmTOR-pathway inhibitor-GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases. Currently unlisted public company. 03/11/23. . 23% 16. Add KZA (ASX) to my watchlist. 465. Application for quotation of securities - KZA. 8m in funding, unless something happens to boost funds. ASX - By Stock. , page-15. 0 Great analysis. Created with Sketch. Advertise. ASX - Short Term Trading. Micro-X Limited designs, develops, manufactures, and commercializes medical and security imaging products using cold cathode X-ray technology for the healthcare and security markets in Australia. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. Join the HotCopper ASX share market forum today for free. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. , page-2. , page-3. What would happen to the share price if KZA went it alone in marketing pAX. Market Cap $17. Add KZA (ASX) to my watchlist (20min delay). Bank of New York Mellon purchase for the US Deposit Holders no doubt. 49% 8. 0¢ Sentiment: Hold Disclosure: Held. , page-2. ASX - By Stock. ASX - Day Trading. Latest Posts. 42. ASX - By Stock. ASX - By Stock. Forums. ASX - Day TradingKZA Price at posting: 8. Does this mean the Kazia phase 2 trial is over?Kazia’s own phase II study of paxalisib in glioblastoma has completed dosing, with the finalpatient on. Application for quotation of securities - KZA. Kazia announces short term unsecured Promissory NoteTipRanks shows the blogger sentiment and article distribution of Kazia Therapeutics Ltd (AU:KZA), a biotechnology company that develops cancer treatments. . 0. 38 PER SHARETo further explain - it was only 17 months from the start of the trial, to that 1 Aug 2022 KZA announcement. 0¢ Sentiment: Hold Disclosure: Held. . , page-2053. KZA up nearly 300% (from 250% around a couple of weeks ago) NOX at near zero 0% MSB down approx 20% KTRA (NASDAQ) down approx 90% it’s obvious Paxalisib is seen to be the superior compound So it’s very clear that Paxalisib has great support from: - our management team - our science board - our independent trial partners It is very difficult to manage a company and at the same time increase the company's share value , with the utmost respect to KZA , I feel it is time for management to hand over the reigns to a new team , who can bring renewed enthusiasm to ways of improving value to KZA share holders . Currently unlisted public company. , page-7. ASX - By Stock. as the tweets were about) which seems to have been. 16. . CA-A Cancer Journal for Clinicians. . 00%. ASX - Day TradingJan 16 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA ANNOUNCES PLACEMENT OF A$4. Created with Sketch. ASX - Day TradingCreated with Sketch. After market transaction 420,000 @ $0. 0 Great analysis Created with Sketch. 0 MILLIONBrM have been shown to have enriched PI3K signaling activity and that PI3K is a master regulator of. Snowflake Score. Kazia share purchase planBack to good old red, the tried and tested color that KZA investors love most. Future Growth. Valuation. I find it so strange that the volume is so low most of the time . 27. 36 79993 Canadian Dollars. Next stop 70 cents. Canadian Dollar. ASX - By Stock. e. 477 AUD for KZA. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAMore thoughts to ponder- while we wait We constantly here that the top 20 have been buying up and increasing their holdings- FOMO imo The top 20 and the. I know GBM AGILE recruited quickly - but simply not possible, for randomized comparison, for pax in GBM AGILE, within that timeframe. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. 1% 7. ASX - Day Trading. This is MASSIVE news, expect novogen to skyrocket when they formally release the results. . A reversal at $0. British Medical Journal unlikely. Join the HotCopper ASX share market forum today for free. 000(0. ASX - By Stock. Market Cap $12. It is very difficult to manage a company and at the same time increase the company's share value , with the utmost respect to KZA , I feel it is time for management to hand over the reigns to a new team , who can bring renewed enthusiasm to ways of improving value to KZA share holders . 56 to $0. Market . . Forums. . Add KZA (ASX) to my watchlist (20min delay) Last 8. Latest Posts. rights. Forums. Change in substantial shareholder interestHotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. KZA. Who knows which way it will go over coming weeks. Created with Sketch. Created with Sketch. ASX - Day TradingCreated with Sketch. A reversal at $0. ASX - By Stock. ASX - General. Our strategy identified two additional CNS penetrant experimental compounds GDC-0084 and bimiralisib. Forex. . 136. ASX - Day TradingCreated with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. , page-9. (closed case). The company announced its paxalisib treatment has been awarded a Fast Track Designation (FTD) by the US Food & Drug Administration (FDA). Aug 11 (Reuters) - Kazia Therapeutics Ltd (KZA) : RESIGNATION OF IAIN ROSS AS CHAIRMAN ELECTED JOHN FRIEND AS INTERIM CHAIRMANAs many have observed over a short period of time the sellers of KZA have dropped, it is now standing at only 9 seller and less than 59,220 shares to sell. metastasis-promoting microglia/macrophages. . KZA (ASX) Chart Featured News. Created with Sketch. . Click for more information. Kazia launches new SABWith a brand new year beginning my belief is the best years are ahead of us in life,I also believe Kazia may be able to give some suffering families hope. You have posted about 180 posts in 24 years (since joining hotcopper,. Created with Sketch. Join the HotCopper ASX Stock discussion forum for KAZIA THERAPEUTICS LIMITED. VUL Vulcan boosts Europe's Largest Lithium Resource: Zero Carbon Lithium™ Project sees enhanced efficiency and sustainability HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. A reversal at $0. 730995 USD. Latest Posts. when from here will we double our S. Latest Posts. Created with Sketch. It might be expected that the board and senior management would at least take a cut in remuneration. Market open. ASX - General. ASX - Day TradingKZA Price at posting: 8. ASX - Day Trading. International Markets. 5 -1. 81M. Kazia Therapeutics Limited (KZA), an ASX-listed company, is an oncology-focused drug development company, based in Sydney, Australia. ASX - By Stock. (like this, which is good. 0. . SYDNEY, Aug. Share "first two Australian patients, now 30- and 31-months post diagnosis (continuing), effectively trebling survival. ASX - Day Trading. Forums. Up nearly 35% And not showing any signs Of slowing down. ASX - Day Trading. Market . Share To give you an idea of the growth june 2017 top was at %55 and all you needed was 160,000 to be in the top 20 Now it is 66% and you need to be over 225,000 to be in the top 20. Commodities. Good luck all. The 3rd Glioblastoma Drug Development Summit - January 18-20,. Future Growth. 0. Market . ASX - By Stock. Created with Sketch. . Australia's largest stock trading and investment forum Australia's #1 stock forum Share Stage 1 recruitment is stopped simply because the patient cap has been reached, and not because of futility or inadequate safety. 5. 495 and $0. KZA. Created with Sketch. ASX - By Stock. ASX - By Stock. ASX - By Stock. - KZA have a market cap of only $25m - Considering it's prime drug candidate is linked with Roche - Genentech a $240b company - no buyers or interest at all - P hopper selling out atone of the most significant time in company's history - before results share. . Latest Posts. The fallacy that is spread around 'it's great that they aren't reporting on time, as patients are living longer' is just that; a fallacy!Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Latest Posts. ASX - General. Market . . 99M. More. Charts. 2023 National Workshops in. 5B pa. -----This came of out of left field: NOVOGEN TO LICENSE SELECT PRECLINICAL PROGRAMS TO HEATON-BROWN LIFE SCIENCES Sydney, 13 November 2017 – Novogen Ltd (ASX: NRT; NASDAQ: NVGN), an Australian oncology drug development company, is pleased to announce that it has entered into an agreement to. ASX - Day TradingVery impressive 2020 AGM Chairman's address and CEO presentation last Friday. Created with Sketch. It often gets busy and loud between. 0000. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. This constitutes a price movement of 3. , page-7. But don't blame other factors, the CEO must move forward with more aggressive promotion, of the company. - for cd ctc socal apch at 800-448-3724. ASX - Day TradingCreated with Sketch. . 5, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ:KZIA, ASX: KZA))), an oncology-focused drug development company, is pleased to announce the presentation of promising new data from an ongoing phase I clinical trial of paxalisib in combination with radiotherapy for the treatment of brain metastases,. Created with Sketch. Forums. Bring on Wednesday trading in Aus! CnS, page-5. Forums. , page-7. Next stop 70 cents. Okay guys I look for medium term trades that are 1) de-risked i. Kazia Therapeutics Ltd sentiment based on opinions from HotCopper and others. TZL. Market . All in all top 20 has again increased it. ASX - Day TradingThinking of buying KZA tomorrow morning. Share" Kazia CEO, Dr James Garner, commented, “China is one of the world’s largest pharmaceutical markets, with specific requirements and opportunities for innovative Potential exhaustion levels for the current pullback are $0. ASX - Day Tradingmay 1 (reuters) - kazia therapeutics ltd (kza) : chief executive officer and managing director james garner has resigned john friend will immediately. . Latest Posts. May 19, 2023 – 11. Join the HotCopper ASX share market forum today for free. . ASX - Short Term Trading. Currently unlisted public company. Charts. looks like another new collaboration trial will begin some time next year… “These are very promising data,” commented Professor Rao, Principal Investigator on the project. Created with Sketch. Can I suggest to you, like many - you have been caught up in. Created with Sketch. Within the next few days the 2,391,865 shares issued on 30/4/21 at $1. Interestingly John Friend’s last few appointments have a 1. . 03/11/23. I say 11th Feb . On other threads the focus seems to have shifted to back and forth criticism of individual contributors and the company board and management. Commodities. Latest Posts. Regards. Forums. ASX - By Stock. 52 would see the support line of the uptrend remain. Kazia's anticipated Key Milestones and Newsflow schedule over the next 7. , page-2. A reversal at $0. Recently. The real miss here is how long have different patients been on therapy, what sort of responses, if any, have been seen. Created with Sketch. ASX - By Stock. Created with Sketch. . We have 2 RPD. . Market . . . . 15am. Created with Sketch. Add KZA (ASX) to my watchlist. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. Kazia's paxalisib granted Fast Track Designation by FDA, page-2. )Nope just got accumulating DLS & STO for the last couple of months and things have paid off - will never replace what I missed out on SBM though (hey plough) - I just want to curl up into a ball - I was so close to slamming a large wad on them under 10c and 1 year later they are $1. KZA. , page-23. ASX - Day TradingMX1 Stock Overview. 5¢. Since the publication of SOLAR-1, we have incorporated the use of alpelisib into our patients with hormone. Regards. , page-2. Just for some fun. Looks like the US stock market might be in for some near term better days - given KZA is clearly a risk on asset this could bode well for the near future KZA Price at posting: 13. 52, $0. Created with Sketch. 58pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on PARADIGM BIOPHARMACEUTICALS LIMITED. About the company. ASX - By Stock. Created with Sketch. Buy your tickets now limited seats. As a not. Just not possible to value now, even given this is only a Phase 2 trial. 25M. 42. Commodities. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. . ASX - Day Trading. Potential exhaustion levels for the current pullback are $0. 6 MILLION VERSUS LOSS A$13. 62 as at the end June 2022This is a reduction of 60%This in despite of the. You have posted about 180 posts in 24 years (since joining hotcopper, I note) - and now posting seemingly everyday. 7,123 Posts. 0¢ Sentiment: Hold Disclosure: Held. 0¢. That's equiv. Hishenk up huge 441,424 since July till today Jackson sold 21,007 and Heaton sold 28,633 in the same month. Market Cap $21. 8081 -0. Cancer-fighting biotech Kazia Therapeutics (ASX:KZA) has received another approval from US health authorities, as it continues with phase II clinical trials for its brain cancer treatment. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of. in a post an hour ago, is simply not correct. Share I love paxalisib, evt801 has real potential. Created with Sketch. 0¢ KAZIA THERAPEUTICS LIMITED - Discussion. Regards. Latest Posts. 38cent options why he left, if it was voluntary. ASX - By Stock. Created with Sketch. ASCO guidelines in HER2+ BCBM - Open questions/next steps, Conclusions. Forums. Kazia joins GBM Agile, page-3. Thought I would start a thread about examples of suspicious looking pricing and ordering action. Feb 23 (Reuters) - Kazia Therapeutics Ltd (KZA) : LOSS FOR HALF-YEAR ATTRIBUTABLE A$13. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held. MX1 fundamental analysis. , page-14. So sorry I could not be their for my big reward with you guys but still I would love to say one last. . 52 would see the support line of the uptrend remain. . Target our investor community with our suite of Hotcopper Advertising opportunities. Created with Sketch. This time coincides exactly with the companies schedule for release of clinical data in breast cancer brain metastases. ASX - Day TradingAre you a Company Director ? Put your Investment Case to Hotcopper's 700K monthly unique visitors. Forums. 465. Discussion. Created with Sketch. Application for quotation of securities - KZA. ASX - Day Trading. "This systematic review provides a. The 2nd ever Annual SNO Brain Metastases Conference, originally planned for Toronto from 13 to 15th August will be virtual this year. $0. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. IPOs. 0¢ Sentiment: Buy Disclosure: HeldKazia GDC-0084 SNO poster, page-3. 0 Great analysis. I like this KZA style but traders follow the noise to sell on the pumps and buy on the dumps - in 2015 this changed after what felt like the mother. ASX - Day TradingTop 8 Medical Journalsonesurfed, maybe these can be narrowed these down further. ASX - Day TradingShare I hold my KZA shares in a Commsec SMSF account with me and my wife as the 2 directors, when this announcement was made I immediately lodged an application to open an international share trading account with Commsec and have been sitting around waiting for the paperwork to process. 12% gap between the sell and buy orders now.